Home
/ OUELH
/ Competitors

OUELH Competitors and Similar CompaniesClear all

OUELH's competitors and similar companies include Sanmed, Teva Pharmaceuticals, Presspart Manufacturing UK and Svas Biosana.

	OUELH OUELH (OUE Lippo Healthcare) is a diversified company in the business areas of healthcare and real estate investment.	Sanmed Sanmed is a manufacturer, supplier, and exporter of disinfectants and antiseptics.	Teva Pharmaceuticals Teva Pharmaceuticals is a company that manufactures generic drugs.	Presspart Manufacturing UK Presspart Manufacturing UK is a company that manufactures drug delivery devices and pharmaceutical components.	Svas Biosana Svas Biosana is a manufacturer and distributor of medical devices and drugs.
Founding Date	Founding Date 2010	Founding Date 2013	Founding Date 1935	Founding Date 1970	Founding Date 1972
Type	Type Public	Type Private	Type Public	Type Subsidiary	Type Private
Tags	Tags Business Products & Services Healthcare Real Estate & Construction conglomerates drug development medical devices	Tags Healthcare drug development medical devices	Tags Healthcare drug development medical devices	Tags Manufacturing & Industrial medical devices paper and packaging	Tags Healthcare drug development medical devices
Locations	Locations HQ	Locations Madhapur, IN HQ	Locations Petah Tikva, IL HQ Ceska Republika, CZ Recepce, CZ	Locations Blackburn, GB HQ Xi'an, CN Marsberg, DE Mumbai, IN Singapore, SG L'arboç, ES Nidau, CH see more	Locations Somma Vesuviana, IT HQ
Employees	Employees N/A	Employees 771% increase	Employees 40,039	Employees N/A	Employees 1311% increase
Financial
Revenue (est.)	Revenue (est.) $152.4m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) £39m (FY, 2021)	Revenue (est.) N/A
Cost of goods	Cost of goods $35.1m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods £26.2m (FY, 2021)	Cost of goods N/A
Gross profit	Gross profit $117.6m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit £12.8m (FY, 2021)	Gross profit N/A
Net income	Net income $8.6m (FY, 2025)	Net income N/A	Net income N/A	Net income £5.6m (FY, 2021)	Net income N/A